Company Registration No. 12003605 (England and Wales)
Anjin Preclinical Ltd
Unaudited accounts
for the year ended 31 May 2023
Anjin Preclinical Ltd
Unaudited accounts
Contents
Anjin Preclinical Ltd
Company Information
for the year ended 31 May 2023
Directors
Elizabeth Anne Kelly
Michael Douglas Kelly
Company Number
12003605 (England and Wales)
Registered Office
2 HIGH HOUSE COTTAGES
PRESTON CROSS
LEDBURY
HR8 2LH
UNITED KINGDOM
Anjin Preclinical Ltd
Statement of financial position
as at 31 May 2023
Tangible assets
7,358
5,379
Cash at bank and in hand
752,426
642,777
Creditors: amounts falling due within one year
(119,796)
(111,966)
Net current assets
672,076
591,633
Net assets
679,434
597,012
Profit and loss account
679,434
597,012
Shareholders' funds
679,434
597,012
For the year ending 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 13 February 2024 and were signed on its behalf by
Elizabeth Anne Kelly
Director
Company Registration No. 12003605
Anjin Preclinical Ltd
Notes to the Accounts
for the year ended 31 May 2023
Anjin Preclinical Ltd is a private company, limited by shares, registered in England and Wales, registration number 12003605. The registered office is 2 HIGH HOUSE COTTAGES, PRESTON CROSS, LEDBURY, HR8 2LH, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% - Straight Line Method
4
Tangible fixed assets
Computer equipment
Amounts falling due within one year
Trade debtors
36,598
60,822
Accrued income and prepayments
2,848
-
Anjin Preclinical Ltd
Notes to the Accounts
for the year ended 31 May 2023
6
Creditors: amounts falling due within one year
2023
2022
Taxes and social security
64,129
100,432
Loans from directors
20,432
8,539
7
Transactions with related parties
Loan from director, 0% interest, and no set repayment date.
E A Kelly - £10,216 (2022) £4,269
MD Kelly - £10,216 (2022) £4,269
8
Average number of employees
During the year the average number of employees was 2 (2022: 2).